Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer
Clinical trial NCT02546661 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02546661
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-28
- Primary completion
- 2020-03-18
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.